| Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza N Landry, BJ Ward, S Trépanier, E Montomoli, M Dargis, G Lapini, ... PloS one 5 (12), e15559, 2010 | 337 | 2010 |
| A clinical trial of a whole-virus H5N1 vaccine derived from cell culture HJ Ehrlich, M Müller, HML Oh, PA Tambyah, C Joukhadar, E Montomoli, ... New England Journal of Medicine 358 (24), 2573-2584, 2008 | 309 | 2008 |
| Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2 SS Ahmed, W Volkmuth, J Duca, L Corti, M Pallaoro, A Pezzicoli, A Karle, ... Science translational medicine 7 (294), 294ra105-294ra105, 2015 | 302 | 2015 |
| Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine G Galli, K Hancock, K Hoschler, J DeVos, M Praus, M Bardelli, C Malzone, ... Proceedings of the National Academy of Sciences 106 (19), 7962-7967, 2009 | 297 | 2009 |
| SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma E Andreano, G Piccini, D Licastro, L Casalino, NV Johnson, I Paciello, ... BioRxiv, 2020 | 281 | 2020 |
| Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice A Wack, BC Baudner, AK Hilbert, I Manini, S Nuti, S Tavarini, H Scheffczik, ... Vaccine 26 (4), 552-561, 2008 | 246 | 2008 |
| MF59®-Adjuvanted H5N1 Vaccine Induces Immunologic Memory and Heterotypic Antibody Responses in Non-Elderly and Elderly Adults A Banzhoff, R Gasparini, F Laghi-Pasini, T Staniscia, P Durando, ... PloS one 4 (2), e4384, 2009 | 220 | 2009 |
| SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma E Andreano, G Piccini, D Licastro, L Casalino, NV Johnson, I Paciello, ... Proceedings of the National Academy of Sciences 118 (36), e2103154118, 2021 | 219 | 2021 |
| Extremely potent human monoclonal antibodies from COVID-19 convalescent patients E Andreano, E Nicastri, I Paciello, P Pileri, N Manganaro, G Piccini, ... Cell 184 (7), 1821-1835. e16, 2021 | 212 | 2021 |
| Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy G Apolone, E Montomoli, A Manenti, M Boeri, F Sabia, I Hyseni, L Mazzini, ... Tumori Journal 107 (5), 446-451, 2021 | 199 | 2021 |
| Evaluation of SARS‐CoV‐2 neutralizing antibodies using a CPE‐based colorimetric live virus micro‐neutralization assay in human serum samples A Manenti, M Maggetti, E Casa, D Martinuzzi, A Torelli, CM Trombetta, ... Journal of medical virology 92 (10), 2096-2104, 2020 | 190 | 2020 |
| Cross-protection by MF59™-adjuvanted influenza vaccine: Neutralizing and haemagglutination-inhibiting antibody activity against A (H3N2) drifted influenza viruses F Ansaldi, S Bacilieri, P Durando, L Sticchi, L Valle, E Montomoli, G Icardi, ... Vaccine 26 (12), 1525-1529, 2008 | 154 | 2008 |
| Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants E Andreano, I Paciello, G Piccini, N Manganaro, P Pileri, I Hyseni, ... Nature 600 (7889), 530-535, 2021 | 149 | 2021 |
| Epidemiology and prevention of Human Papillomavirus I Manini, E Montomoli Ann Ig 30 (4), 28-32, 2018 | 147 | 2018 |
| Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects R Gasparini, T Pozzi, E Montomoli, E Fragapane, F Senatore, M Minutello, ... European journal of epidemiology 17, 135-140, 2001 | 142 | 2001 |
| Current adjuvants and new perspectives in vaccine formulation E Montomoli, S Piccirella, B Khadang, E Mennitto, R Camerini, A De Rosa Expert review of vaccines 10 (7), 1053-1061, 2011 | 134 | 2011 |
| Influenza immunology evaluation and correlates of protection: a focus on vaccines CM Trombetta, E Montomoli Expert review of vaccines 15 (8), 967-976, 2016 | 125 | 2016 |
| Overview of serological techniques for influenza vaccine evaluation: past, present and future CM Trombetta, D Perini, S Mather, N Temperton, E Montomoli Vaccines 2 (4), 707-734, 2014 | 118 | 2014 |
| Antibody response against heterogeneous circulating influenza virus strains elicited by MF59-and non-adjuvanted vaccines during seasons with good or partial matching between … F Ansaldi, M Zancolli, P Durando, E Montomoli, L Sticchi, G Del Giudice, ... Vaccine 28 (25), 4123-4129, 2010 | 106 | 2010 |
| Water and air ozone treatment as an alternative sanitizing technology M Martinelli, F Giovannangeli, S Rotunno, CM Trombetta, E Montomoli Journal of preventive medicine and hygiene 58 (1), E48, 2017 | 103 | 2017 |